Methylation of hMLH1 in a population-based series of endometrial carcinomas

Clinical Cancer Research

Volumn 6, Issue 9, 2000, Pages 3607-3613

  Salvesen, H B ^a   Macdonald, N ^a   Ryan, A ^a   Iversen, O E ^a   Jacobs, I J ^a   Akslen, L A ^a   Das, S ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; PROTEIN P53;

ADULT; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DIPLOIDY; DNA METHYLATION; ENDOMETRIUM CARCINOMA; FEMALE; GENE FREQUENCY; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION;

BASE PAIR MISMATCH; CARRIER PROTEINS; CELL NUCLEUS; DNA METHYLATION; DNA REPAIR; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MICROSATELLITE REPEATS; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS;

EID: 0033813298     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease
2. Cancer risk associated with germline DNA mismatch repair gene mutations
3. Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer
4. Microsatellite instability in cancer of the proximal colon
5. Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer
6. hMLH1 Promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability
7. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma
8. Genetic instability of microsatellites in endometrial carcinoma
9. Microsatellite instability in sporadic endometrial carcinoma
10. Deletion mapping on chromosome 10q25-q26 in human endometrial cancer
11. Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas
12. Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers
13. Causes and consequences of microsatellite instability in endometrial carcinoma
14. Cancer epigenetics comes of age
15. 5' CpG Island methylation is associated with transcriptional silencing of the tumour suppressor p16/ CDKN2/MTS1 in human cancers
16. Alterations in DNA methylation: A fundamental aspect of neoplasia
17. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
18. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
19. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines
20. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability
21. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers
22. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability
23. MLH1 Promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers
24. MLH1 Promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas
25. Poorer survival for nulliparous women with endometrial carcinoma
26. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas
27. Prognostic significance of angiogenesis and Ki-67, p53 and p21 expression: A population-based endometrial carcinoma study
28. Flow cytometric deoxyribonucleic acid index: A prognostic factor in endometrial carcinoma
29. Independent prognostic importance of microvessel density in endometrial carcinoma
30. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis
31. Diagnostic microsatellite instability: Definition and correlation with mismatch repair protein expression
32. Microsatellite instability in endometrial carcinoma
33. Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1
34. Microsatellite instability analysis: A multicenter study for reliability and quality control
35. Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members
36. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics
37. Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas
38. Methylation-specific PCR. A novel PCR assay for methylation status of CpG islands
39. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression
40. Genetic instability in colorectal cancers
41. Life (and death) in a malignant tumour
42. Cell-cycle control and its watchman
43. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas
44. Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability
45. Endometrial carcinoma: The prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression
46. Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma